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Abstract: The present work was conducted to assess the Hematological 
and biochemical toxicity profiles of tramadol during therapeutic use. Male 
adult domestic rabbits (weighting 1000-1300g)  were divided into six groups. 
Group one received vehicle (saline), group two, three and four injected 
intramuscularly  with doses of tramadol equal to 40 mg / kg body weight / 
day for 10, 20 and 30 days respectively followed by 10  days recovery period 
for group three and four. Hematological and Biochemical measurements were 
carried out every 10 days. Control and treated rabbits were sacrificed at the 
end of 10, 20, 30, and 40 days respectively. Blood was collected in dry 
centrifuge tubes. Sera were separated and kept at -20ºC until analysis. 
Administration of tramadol at a dose of 40mg/kg. body weight for 30 days 
increased serum glucose, cholesterol, triglycerides, electrolytes (Na+ and 
Ca2+) and cholinesterase values. Theses increments were 21.53%, 9.64%, 
3.39%, 2.14%, 6.67 and 20% respectively, compared to control level. Also 
there was a significant increase in kidney function indices. The effect was 
more pronounced on creatinine. Activities of serum aspartate 
aminotransferase (AST), alanine aminotransferase (ALT), alkaline 
phosphatase (ALP) and bilirubin were increased following tramadol injection 
to rabbits for 30 days. Concerning hematological parameters, the more 
obvious changes were observed in the increment of white blood cells 
(WBCs), lymphocyte and MCV value and the decrease in hematocrit, 
hemoglobin(Hb), red blood cells (RBCs) count, MCH, MCHC, and platelets 
(PLT) count in response to the administration of tramadol. In general 
recovery periods after tramadol abstinence, showed signs of improvement of 
blood indices. 
Conclusion: Tramadol toxic effects should be avoided during long term 
therapy specially in large doses. 
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   البيوكيميائيةوية وقياسات الدمال بعض إعطاء الترامادول علىتأثير 
  المحلية األرانبفي 
نتيجة  األرانبالدموية في و البيوكيميائية القياساتدراسة بعض  إلىلبحث هذا ايهدف : ملخص
البالغة والتي  المحلية رانباألذكورحيث استخدم في هذا البحث  .امادولرعقار الت اعطاء لتأثير
 40قدرها رعة يومية من الترامادول جرام وأعطيت ج1300-1000يتراوح وزنها ما بين 
ارتفاع في تركيز  إلىدول التراما إعطاء أدى. اًيومكجم من وزن الجسم لمدة ثالثين /ملجرام
حيث  ،ستيريزنيثية والصوديوم والكالسيوم والكولوالدهون الثال الجلوكوز والكولسترول الكلي
على % 20.24 و% 6.67و %2.14و %3.39و %9.64و %21.53 إلىوصلت نسبة الزيادة 
 والكرياتينين البوليكوحمض  البولينا  مقارنة بالمجموعة الضابطة كذلك ارتفع مستوىالتوالي 
زيادة في نشاط األنزيمات الناقلة لمجموعة  أيضاظهرت أوضوحا و أكثر الكرياتينين ارتفاعوكان 
الكلية والزالل  البروتيناتوالفوسفاتيز القاعدي والبيليروبين بينما انخفضت ALT, AST  األمين
والخاليا  الكلي زيادة في عدد كرات الدم البيضاء الكاملة ظهرت صورة الدمأو .والجلوبيولين
 معدل الهيماتوكريت والهيموجلوبين وعدد كرات الدم الحمراء و بينما نقص MCVو الليمفاوية
MCHو MCHCإعطاءالصفائح الدموية مقارنة بمجموعة الحيوانات الضابطة نتيجة  وعدد 
  .االستشفاء فقد تحسنت معظم القياسات السابقةما في مجموعات أ. الترامادول
  .االنزيمات- فلسطين -قطاع غزه - قياسات الدم -األرانب  - الترامادول :الكلمات المفتاحية
  
Introduction 
Tramadol is a centrally acting analgesic agent with activity at μ-opioid, 
adrenergic and 5-hydroxytryptamine (5-HT) receptors. Its analgesic effect is 
a result of its dual mechanism of action, that is, as a re-uptake inhibitor of 
norepinephrine and serotonin and agonist of the μ-opioid receptor 
(Bamigbade et al., 1997; Halfpenny et al., 1999; Ide et al., 2006). Tramadol 
has been in clinical use for the relief of mild to moderate pain in human and 
veterinary medicine (Buback et al., 1996; Yaddanapudi et al., 2000; 
Ozcengiz et al., 2001; Mastrocinque and Fantoni, 2003; Pypendop and 
Ilkiw, 2008). Tramadol is also used perioperatively in veterinary anesthesia 
as it significantly reduces the requirements of volatile anesthetics and opioid 
agents (Wordliczek et al., 2002; Seddighi et al., 2009). 
Although tramadol has relatively effective analgesic effects, a higher 
tramadol infusion rate was needed to reduce sevoflurane requirements in 
dogs (Seddighi et al., (2009). Furthermore, recent results showed that 
tramadol exhibits different metabolic rates between species: tramadol is 
metabolized quickly to inactive metabolites in goats, horses and dogs 
(KuKanich and Papich, 2004; de Sousa et al., 2008; Shilo et al., 2008; 
The Effects of Tramadol Hydrochloride Administration on 
53 
Giorgi et al., 2009b), in contrast with cats and camels (Elghazali et al., 
2008; Pypendop and Ilkiw, 2008). 
Tramadol has a dose- dependent analgesic efficacy that lies between that of 
codeine and morphine, with a parenteral potency comparable to that of 
pethidine, i.e. about 10- 20 % of the standard morphine (Wilder- Smith et 
al., 1999; Pang et al., 2003). 
The central role of liver and kidney in drug metabolism predisposes them to 
toxic injury. Every drug has been associated with hepatotoxicity almost 
certainly due to the pivotal role of the liver in drug metabolism. Hepatic 
metabolism is, first and foremost, a mechanism that converts drugs and 
other compounds into products that are more easily excreted and that 
usually have a lower pharmacologic activity than the portent compound 
(Poppers 1980; Tolman 1998). A metabolite may have higher activity and/or 
greater toxicity than the original drug. Metabolites of the drugs that are 
excreted from kidneys may also cause cellular damage leading to kidney 
dysfunction (Singhal et al., 1998). 
Tramadol is also thought to have some NMDA-type (N-methyl-D-aspartate) 
antagonist effects, which has given it a potential application in neuropathic 
pain states (Lintz et al., 1998). Increasing serotonin and norepinephrine may 
also reduce inflammatory cytokines which are released by the brain in 
response to stress. The inflammatory cytokines would have slowed down 
recovery from a workout or illness - impairing one's immune system and 
healing, thus tramadol may have an anti-inflammatory effect (Bianchi et al., 
1999; Barkin, 2008).Tramadol carries all possible risks known from other 
opiates (Cicero et al., 2005; Adams et al., 2006). Side effects include 
dizziness, headache, somnolence, nausea, constipation, sweating, pruritus, 
and central nervous system stimulation (Reig, 2002; Kabel and van 
Puijenbroek, 2005). Tramadol causes respiratory depression, although 
usually weaker than that seen with other opiates and opioids (Senay et al., 
2003). 
Thus, the present study aims to investigate the hematological and 
biochemical effects of tramadol in rabbits. 
Materials and methods 
Experimental animals and dosing 
The used adult rabbits in the present study were weighting 1000-1300g. 
They were purchased from local markets. Rabbits were left in the animals 
house for 1 week before experimentation to adapt to laboratory condition. 
They were kept in plastic cages with wire mesh covers and maintained 
under the following conditions: temperature (20ºC– 21ºC), relative humidity 
(40% - 60%) and a light /dark cycle of 14 and 10 hours. The cages were 
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freshly spread by wood saw to absorb urine of animals. Rabbits were given 
free access to commercial balanced diet and water ad libitum all over the 
experimental period. Animals were divide into five groups, as follows: 
The first group was comprised 10 rabbits, served as control and injected 
intramuscularly  with 1ml of saline solution for a month. The second, third 
and fourth groups, each comprised 6 rabbits, were administered 
intramuscular  doses of 40 mg /Kg b. wt. /day  tramadol HCl for a 10,20 and 
30 days respectively (according to Sebnem et al., 2005). Six rabbits from 
third and fourth tramadol groups were left ten days more without any 
additional treatment as a recovery period after exposure. 
All chemicals used were of analytical grade and were procured from Sigma 
Chemical Company Germany. Tramadol HCl (Tramal Ampoule) was 
purchased from Pharmacare  Pharmaceutical company, Ramallah, West 
Bank . 
Blood sampling and processing 
Control and treated rabbits were decapitated at the end of 10, 20, 30, and 40 
days, respectively. Blood was collected in dry centrifuge tubes. Sera were 
separated and kept at -20ºC until analysis. However, determinations of 
enzyme activities were carried out on fresh serum samples, Moreover, about 
2 mL of blood samples were collected into a tube containing dipotasium 
ethylene diamine tetra acetate (EDTA) for the hematological tests. 
Measurement of biochemical blood indices  
Serum glucose, triglycerides and total cholesterol were determined using the 
method described by Trinder,(1969) Fossati and Prencipe (1980) and Allain 
et al., (1974) respectively.  Serum  urea measurement was  based  on  the   
cleavage  of  urea  with urease ( Berthelot's reaction) according to Faweett 
and Scott(1960), serum uric acid was determined following the method 
described by Fossati et al.,(1982), serum creatinine was measured without 
protein precipitation according to Bartels et al., (1972). Serum total protein 
was determined according to biuret reaction ass designed by Armstrong and 
Carr, (1963).  
The kits were purchased from Biotech laboratories, UK. Serum albumin was 
determined using RANDOX reagent kits, following their instruction manual 
according to the method of Doumas et al., (1971).   
The concentrations of globulins (g/dL) were equal to  Total protein – 
Albumin. The activities of serum AST and ALT were determined according 
to the method of Reitman and Frankel, (1957) The measurement of serum 
ALP and bilirubin activity was based on the method of Bessey et al.(1946) 
and Perry et al.(1983). Serum cholinesterase activity was measured by 
kinetic photometric test, according to the recommendation of German 
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Society of Clinical chemistry (DGKC), the method described by Ellman and 
his colleagues (Ellman, 1961) using Diasys reagent Kits. Estimation of 
serum Na was conducted by Flame Photometric method (Tietz,1990). 
Estimation of serum Ca was done by Gitel man(1967) method. 
Hematological parameters 
Determination of hematological parameters was carried out using an 18 





Data were computer analyzed using SPSS version 11.0 for windows 
(Statistical Package for the Social Sciences lnc. Chicago, Illinois, USA). 
Means were compared by independent-samples test , p<0.05 was considered 
as significant. Percentage change was also calculated. 
 
Table (1):Effect of Tramadol (40 mg/kg/day) Administration on Glucose, 









































































































All values were expressed as mean ± S.E;   P<0.05 significant; P<0.01 highly significant 
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Table (2): Effect of Tramadol (40 mg/kg/day) Administration on 














































































































































All values were expressed as mean±S.E; P<0.05 significant; P<0.01 highly significant 
 
Table (3): Effect of Tramadol (40 mg/kg/day) Administration on 
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All values were expressed as mean ± S.E; P<0.05 significant; P<0.01 highly significant 
 
 
Table(4) effect of Tramadol (40 mg/kg/day) Administration on Total 










































































































































































































[All values were expressed as mean ± S.E; P<0.05 significant; P<0.01 highly significant 
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Results 
Serum glucose, triglycerides and total cholesterol, mean values of rabbits 
affected by tramadol with/ without recovery are summarized in table (1). 
The data revealed that administration of tramadol for 30 days increased 
serum glucose level by 21.53% compared the control level. But after 
withdrawal of the drug the previous increment of serum glucose was 
reduced to 0.44% and 15.98% respectively, compared to the control level. 
while, triglycerides increased gradually and non-significantly from the first 
ten days treatment till one month (p > 0.05). On the other hand, mean values 
of serum cholesterol was non-significantly increased by 9.64 % in tramadol 
treated rabbits for 30 days compared to the control. Also, there was gradual 
higher significant increase in bilirubin observed at 10,20 and 30 days (p< 
0.01) . The recovery group was noted to be significantly elevated over 
corresponding control group. 
Table (2) showed that administration of 40 mg tramadol /Kg body wt./day 
significantly decreased serum total protein by -12.64, - 16.27 and -14.89 % 
at 10, 20 and 30 days respectively (p< 0.01). Also, serum Albumin 
concentration under the influence of tramadol for 10,20 and 30 days 
decreased by 18.99, 22.78 and 12.66% respectively. Moreover, table (2) 
shows a non-significant decrease in globulin concentration after tramadol 
treatment for 10 and 20 days(p> 0.05), and highly significant decrease at 30 
days (p< 0.01). Values of the recovery group was noted to be significantly 
decreased over corresponding control group. 
Non protein nitrogenous constituents concentration in rabbits serum after 
administration of tramadol and the therapeutic action of recovery are 
tabulated in table (2). In general, intramuscular administration of tramadol 
increased urea, uric acid, and creatinine concentration compared to control 
level. The effect of tramadol was more pronounced on creatinine. However 
withdrawal of  donates tramadol lowered these elevated values. 
Table (3) indicated that administration of 40 mg tramadol /Kg body wt./day  
increased significantly the level of cholinesterase, ALT, AST and ALP at 
10, 20 and 30 days of treatment (p< 0.01). The ten days recovery group 
remained significantly different compared to control group. In general, 
administration of tramadol increased sodium and calcium compared to 
control level at the different intervals of the experiment (table 3). 
Table (4) shows blood indices in rabbits after administration of 40 mg 
tramadol /Kg body wt./day. The more obvious changes that resulted from 
the administration of tramadol were an increase in WBC count, lymphocyte, 
MCH  and MCV, but there was a decrease in RBC count, hemoglobin (Hb), 
mean corpuscular hemoglobin concentration (MCHC), hematocrit and PLT. 
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Nevertheless, the recovery groups parameters showed signs of 
improvement. 
Discussion 
Data revealed a general increase in serum glucose levels in rabbits in 
response to tramadol administration. Tramadol may indirectly, play a 
specific role in carbohydrate metabolism probably due to enhancing 
gluconeogenesis and glucose mobilization to the blood (Berne and Levy 
1998 and Bishop et al., 2005). The change observed in serum triglycerides 
and cholesterol content in response to treatment by tramadol drug; take 
place in the liver due to imbalance between the normal rabbits of lipid 
synthesis, utilization and secretion (Glasser and Mager,1972). The 
increment in cholesterol and triglyceride content agreed with that reported 
by Parker et al., (1984).The possible explanation of these observed 
increments may be explained  on  indirect action of tramadol on lipid 
metabolism or lipid peroxidation (Berne and Levy, 1998). 
Urea is the principal end product of protein catabolism an accelerated amino 
acid deamination for gluconeogenesis is probably an acceptable postulate to 
interpret the elevated level of urea. The increment in blood urea, might be 
also due to the destruction of RBCs during the treatment. The presence of 
some toxic compounds might increase blood urea and decrease plasma 
protein (Varely 1976). On the other hand the elevation of blood urea might 
suggest that animals experienced hemoconcentration due to mild 
dehydration (Debra Manzell, 2008). 
Moreover, the serum uric acid levels exhibited an increase in the treated 
rabbits for the experimental duration. This may be due to high degradation 
of purines or an increase of uric acid level by inability of its excretion by 
urinary system (Wolf et al., 1972). Hemolysis of red blood cells may cause 
damage of functioning nephrons and impairers renal function (Bishop et al., 
2005). 
On the other hand, current results indicated an increase in creatinine levels 
in rabbits which      received 40 mg /Kg tramadol after 30 days treatment. 
These results are in accordance with Atici et al. (2005) who reported an 
increase in BUN (Blood Urea Nitrogen) and creatinine levels in rats 
receiving morphine for a month. The significant decreased levels of total 
protein in tramadol treated rabbits could be attributed to an increase in 
amino acids deamination. This decrease in serum total protein may be due to 
lowered synthesis of albumen and globulin in the liver in response to 
tramadol intake. It was reported that albumin levels are decreased in liver 
disease (Nyblom et al.,2004). The decrease in these blood proteins of the 
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rabbit may be due to usage of different amino acids in the production of 
antibodies in response to tramadol administration. 
The significant increase in serum cholinesterase observation in the present 
work may be attributed to the idea that tramadol binds to acetylcholine 
receptors, leading to increase acetylcholine levels. The activity of 
cholinesterase enzyme leads to breaks down the excess acetylcholine i.e. 
increase cholinesterase activity recorded in the present work (Ides et al., 
2006). After re repeated oral administration of tramadol in humans 
(Marthinesen et al., 1998), the main signs of intoxication include central 
nervous symptoms, from vomiting to convulsions or eventually anoxic brain 
damage (Spiller et al., 1997). 
Serum transaminases (AST&ALT) and bilirubin exhibited a highly 
significant increase in tramadol treated rabbits compared to the control. As a 
liver specific enzyme ALT only significantly elevated in hepatobiliary 
disease. Increase in AST level, however, can occur in connection with 
damages of heart or skeletal muscle as well as of liver parenchyma (Moss 
and Handerson 1999) and Vozarova et al., (2002).  
The liver and kidney are responsible for tramadol metabolism and excretion. 
It may cause hepatotoxicity and nephrotoxicity during its metabolism (Wu 
et al., 2001; Janssen- Ortho Inc., 2005). Borzelleca et al. (1994) reported 
increased in ALT, AST and LDH activities in rats after long- term usage of 
morphine-like agent; levo-alpha-acetylmethadol HCl (LAAM). Also, a 
significant increase in the levels of ALT, LDH and lipid peroxides was 
reported among chronic heroin users (Panchenko et al., 1999). Similarly, the 
present data showed significant increase in the levels of ALT and AST 
among rabbits received doses of tramadol (40 mg /Kg body wt.) . 
Consequently, elevated ALT and AST activities observed in the current 
study in response to tramadol administration could be a common sign of 
impaired liver function.  ALP present in cell surface in most human tissues. 
The highest concentration are found in the intestine, liver bone, spleen and 
kidney  (Gitnick et al., 1992) and Moss and Handerson (1999) . The specific 
location of the enzyme with both sinusoidal and bile canalicular membranes 
accounts for the more predominant elevations in certain disorders as 
observed in the present study with tramadol administration. Impaired 
secretion of hepatic ALP of liver cell origin may be accompanied by acute 
cell necrosis, so  liberation of ALP in the circulation is elevated.  The 
cellular injury may still persist as indicated by increased AST, ALT and 
ALP activities. The findings of the current investigation were in agreement 
with the findings of  Sebnem et al., (2005) who reported that the levels of 
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ALT, AST, LDH and Blood urea nitrogen (BUN), and creatinine were 
significantly higher in morphine grouped compared to the control group. 
The findings also revealed a general increase in calcium and sodium levels 
in rabbits in response to tramadol administration. Serum level of 
electrolytes: (Na+), (K+), (Ca2+) and (Po43+) may be affected as a result of 
tissue damage due to hypoxia and asthmatic medication (Kolski et al 1988). 
The present findings  also showed significant increase of total WBCs count 
and lymphocyte. This significant increase in WBCs count indicated the 
activation of defense mechanism and immune system of rabbit. This 
induction of white blood cells is a positive response for survival due to cell 
mediated immune response of animals (Kollar and Roan, 1980). 
Leukocytosis was manifested by lymphocytosis, which was the main 
features of the differential leukocytic count. 
The red blood cells(RBCs) count showed a general decrease in response to 
tramadol administration. This finding may be explained on the basis of 
inhibitory effect of tramadol on histogenesis. The decreased in RBC count 
and hemoglobin (Hb) lowered the oxygen supply to different tissues thus 
resulting in low energy production. Decrease in Hb contained MCH can be 
explained due to decreased size of RBC or impaired biosynthesis of heme in 
bone marrow. These findings are in agreement with the reported decrease in 
RBC count and Hb content after treatment with tramadol (Goeringer et al., 
1997). 
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